Comparative pharmacoeconomic effectiveness of interleukin-17 inhibitors for the treatment of ankylosing spondylitis

Comparative pharmacoeconomic effectiveness of interleukin-17 inhibitors for the treatment of ankylosing spondylitis

Objective – to compare the clinical efficacy and cost-effectiveness of IL-17 inhibitors (SEC, IXE, NTK) in the treatment of adult patients with ankylosing spondylitis (AS) in the healthcare system of the Russian Federation.Material and methods. The study is a sub-analysis of a previously published s...

Full description

Bibliographic Details
Main Authors: T. V. Dubinina, I. Z. Gaydukova, N. А. Sableva, K. V. Sapozhnikov, V. D. Sokolova, D. G. Tolkacheva
Format: Article
Language:Russian
Published: IMA PRESS LLC 2022-12-01
Series:Научно-практическая ревматология
Subjects:
ankylosing spondylitis
genetically engineered biological agents
biologics
interleukin 17 inhibitor
network meta-analysis
Online Access:https://rsp.mediar-press.net/rsp/article/view/3249

Internet

https://rsp.mediar-press.net/rsp/article/view/3249

Similar Items